MTOR and neoplasm: This combination enhanced attenuation of the PI3K/Akt/mTOR pathway more than EGFR inhibitor alone, including enhancing the tumour cell killing effect, which is unsurprising given the positive role of CK2 in phosphorylating prosurvival Akt [129].